JMP Securities Starts OptimizeRX (OPRX) at Market Outperform, 'Comprehensive Biopharma Digital Marketing Platform'
Tweet Send to a Friend
(Updated - April 4, 2024 4:06 AM EDT)JMP Securities analyst Constantine Davides initiates coverage on OptimizeRX (NASDAQ: OPRX) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
